ArticleBMC neurology2026
The relationship between inflammatory markers and the severity and prognosis of neurological dysfunction in stroke patients.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe aim of this study is to explore the relationship of inflammatory indicators with the severity and prognosis of neurological dysfunction in stroke patients, and to evaluate the prognostic value of inflammatory indicators for patients suffering from acute ischemic stroke (AIS).
methodsThe study recruited 225 AIS patients and 46 healthy individuals, and collected their clinical data and hematological indicators. Calculate six inflammatory markers and evaluate the National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) scores at admission, discharge, 1 months of onset and 3 months of onset. Correlation analysis, multivariate logistic regression analyses, the receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to analyze the relationship of inflammatory markers with the severity and prognosis of stroke.
resultsElevated levels of neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and pan immune-inflammation value (PIV) were observed in patients at admission (p < 0.05). Most inflammatory markers are positively correlated with the severity of neurological deficits during the acute phase, especially upon admission and discharge. Higher admission lymphocyte to monocyte ratio (LMR) levels are independently associated with larger infarct volume and adverse functional outcomes. In contrast, indicators like NLR, SIRI and PIV showed associations in the opposite direction (odds ratios < 1), suggesting complex interactions that require further investigation. For different time points, NLR showed the greatest prognostic value at admission (AUC = 0.654) and PIV at discharge (AUC = 0.725).
conclusionsThese inflammatory markers exhibit characteristic dynamic changes after AIS and have close relationship with the severity and prognosis of neurological deficits. It may contribute to early risk stratification and personalized treatment soon after.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.